Business ❯Pharmaceutical Industry ❯Market Competition ❯Drug Pricing

Novo Nordisk

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

FDA Declares Semaglutide Shortage Over, Impacting Compounded Drug Market